Editor- in- Chief

  • Mahmoud Aljurf

    Director, Adult HSCT Program; Deputy Director, Oncology Center; Scientific Director EMBMT; King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia

    Email Mahmoud Aljurf

Associate Editors

  • M.A. Kharfan-Dabaja

    Associate Editor for Hematopoietic Stem Cell Transplantation Senior Member and Professor of Oncologic Sciences, Department of Blood and Marrow Transplantation, Moffitt Cancer Center, University of South Florida, South Florida, United States of America

    Email M.A. Kharfan-Dabaja

  • M. Alshabanah

    Associate Editor for Radiation Oncology;
    Head, Radiation Oncology, Oncology Centre, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia

  • U. Gergis

    Associate Editor for Hematologic Malignancies and Non Neoplastic Hematology;
    Medical Director, Hematology/Oncology for Global Services, Leukemia and Bone Marrow Transplant Service, Weill Cornell Medical College, New York, Unites States of America

  • G. Abu-Alfa

    Associate Editor for Solid Tumors and Cancer Supportive Care Physician, Memorial Solan — Kettering Cancer Center; Associate Professor, Weil Cornell Medical College, New York, USA

Editorial Board

  • A. A. Abbadi

    Professor of Medicine, Hematology and Oncology, University of Jordan and senior consultant in Hematology and Oncology, Jordan University Hospital, Amman, Jordan

  • H. Abdel-Razeq

    Deputy Director General; Chief Medical Officer, King Hussein Cancer Center, Amman, Jordan

  • S. Ahmed

    Consultant, Department of Adult Hematology/ HSCT, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia

  • M. Ajarim

    Riyadh, Saudi Arabia

  • D. Alabdulaaly

    Riyadh, Saudi Arabia

  • A. Albadawi

    Riyadh, Saudi Arabia

  • K. Alimoghaddam

    Hematology, Oncology and stem cell transplantation research center, Tehran University of Medical sciences, Shariati Hospital, Tahran, Iran

  • A. Alkofide

    Riyadh, Saudi Arabia

  • D. Almaguer

    Department of Hematology, Hospital Universitario, Monterrey, Mexico

  • F. Almohareb

    Riyadh, Saudi Arabia

  • M. Alshabanah

    Riyadh, Saudi Arabia

  • H. Alzahrani

    Riyadh, Saudi Arabia

  • M. Arat

    Instanbul, Turkey

  • M. Ayas

    Riyadh, Saudi Arabia

  • A. Bazarbachi

    Beirut, Lebanon

  • S. Bazarbashi

    Riyadh, Saudi Arabia

  • M.A. Bekadja

    Head, Cell Therapy and Hematology Service; President, The Algerian society of Hematology and Blood Transfusion, Oran, Algeria

  • S. Benchekroun

    Department of Hematology, Children Hospital, Casablanca, Morocco

  • T. V. Binh

    Blood Transfusion and Hematology Hospital, Ho Chi Minh city, Vietnam

  • M. Chandy

    Director, Tata Medical Centre, Kolkata, India

  • P. M. Chen

    Taipei Veterans General Hospital and National; Hematology and Oncology, Medical School,Yang-Ming University, Taipei ,Taiwan

  • C. S. Chiattone

    Chief, Department of Hematology, Santa Casa Medical School, São Paulo, Brazil

  • S. Dermime

    Dammam, Saudi Arabia

  • T. Elhassan

    Biostatistician, Oncology Centre, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia

  • H. Elsolh

    Riyadh, Saudi Arabia

  • G. Gan

    Department of Medicine, The Adult Hematology Unit, University Malaya Medical Centre, Kuala Lumpur, Malaysia

  • A. Ghavamzadeh

    Stem cell transplantation research center, Tehran University of Medical Sciences, Shariati Hospital, Kargar Ave, Tahran, Iran

  • A. Hamidieh

    Pediatric Hematologist/Oncologist; Associate Professor of Medicine, Tehran University of Medical Sciences, Tehran, Iran

  • S. Issaragrisil

    Faculty of Medicine, Siriraj Hospital, Division of Hematology, Department of Medicine ,Mahidol University ,Bangkok, Thailand

  • I. Jazieh

    Riyadh, Saudi Arabia

  • Y.M. Khafaga

    Consultant, Section of Radiation Oncology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia

  • Y. Kodera

    Vice-President, Department of Promotion for Blood and Marrow Transplantation, Aichi Medical University School of Medicine, Aichi, Japan

  • M. Koh

    Hematology/ Stem Cell Transplantation, Singapore General Hospital and Health Sciences Authority, Singapore, Singapore

  • B. Labar

    Department of Hematology, University Hospital Center Rebro, Zagreb, Croatia

  • S. Ladeb

    Department of Hematology , Centre National de Greffe de Moelle Osseuse,Tunis ,Tunisia

  • J. Lee

    Division of Hematology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea

  • D. P. Lu

    Fu Dan University, Institute of Hematology; Shanghai Dao-Pei Hospital, Shanghai, China

  • H. Mahmoud

    Department of Medical Oncology, National Cancer Institute, Cairo University, Cairo, Egypt

  • A. Mohiuddin

    Riyadh, Saudi Arabia

  • N. Novitzky

    Professor and Head, Division of Haematology, Departments of Medicine and Pathology, University of Cape Town, South Africa

  • T. Othman

    Department of Hematology, Centre National de Greffe de Moelle Osseuse, Tunis, Tunisia

  • R. Pasquini

    Bone Marrow Transplantation Unit, Hospital de Clínicas, UFPR, Curitiba, Brazil

  • M. Patel

    Division of Clinical Haematology, Department of Medicine, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa

  • J. Pereira

    Department of Hematology- Oncology, School of Medicine, Catholic University of Chile, Santiago, Chile

  • G. Ruiz-Arguelles

    Clinica Ruiz de Puebla, Center for Hematology and Internal Medicine, Monterrey, Mexico

  • T. Shamsi

    Consultant Haematologist and Transplant Physician; Medical Director, National Institute Of Blood Disease and Bone Marrow Transplantation, Karachi, Pakistan

  • T. Wu

    Director, Department. of Bone Marrow Transplantation, Beijing Daopei Hospital, Beijing, China

Publication office staff

  • Nada Albassam

  • Amal Alghammas

  • Jeruly Pangan-Menor

  • Reina Tejano

  • Janelle Vales